Davita Healthcare Partners Stock Today
| DVA Stock | USD 165.51 1.37 0.83% |
Performance4 of 100
| Odds Of DistressLess than 6
|
DaVita HealthCare is trading at 165.51 as of the 24th of November 2024, a 0.83 percent increase since the beginning of the trading day. The stock's open price was 164.14. DaVita HealthCare has only a 6 % chance of going through financial distress over the next few years but had a somewhat insignificant performance during the last 90 days. Note, on January 17, 2024, Senator Jerry Moran of US Senate acquired under $15k worth of DaVita HealthCare's common stock.
Business Domain Health Care Equipment & Services | IPO Date 31st of October 1995 | Category Healthcare | Classification Health Care |
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado. Davita Healthcare operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. The company has 82.02 M outstanding shares of which 4.28 M shares are currently shorted by investors with about 5.44 days to cover. More on DaVita HealthCare Partners
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
DaVita Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| CEO | Javier Rodriguez | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Old Name | Delivra Corp | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Providers & Services, Health Care Equipment & Services, Health Care, NYSE Composite, SP 500 Index, Warren Buffett Holdings, Obamacare, Healthcare, Health Care, Health Care Providers & Services, Medical Care Facilities, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Excise Tax Activities | Animal Testing | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsDaVita HealthCare can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand DaVita HealthCare's financial leverage. It provides some insight into what part of DaVita HealthCare's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DaVita HealthCare Partners (DVA) is traded on New York Stock Exchange in USA. It is located in 2000 16th Street, Denver, CO, United States, 80202 and employs 70,000 people. DaVita HealthCare is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 13.58 B. DaVita HealthCare runs under Health Care Providers & Services sector within Health Care industry. The entity has 82.02 M outstanding shares of which 4.28 M shares are currently shorted by investors with about 5.44 days to cover.
DaVita HealthCare Partners has about 244.09 M in cash with 2.06 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.98.
Check DaVita HealthCare Probability Of Bankruptcy
Ownership AllocationDaVita HealthCare holds a total of 82.02 Million outstanding shares. Over half of DaVita HealthCare's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that obtain positions in a given instrument to benefit from reduced trade commissions. Please note that on January 17, 2024, Senator Jerry Moran of US Senate acquired under $15k worth of DaVita HealthCare's common stock.
Check DaVita Ownership Details
DaVita Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Allianz Asset Management Ag | 2024-06-30 | 538.7 K | |
| Charles Schwab Investment Management Inc | 2024-09-30 | 501.6 K | |
| Jpmorgan Chase & Co | 2024-06-30 | 470.1 K | |
| Bank Of America Corp | 2024-06-30 | 452.6 K | |
| Bank Of New York Mellon Corp | 2024-06-30 | 446.5 K | |
| Citadel Advisors Llc | 2024-09-30 | 433.8 K | |
| Legal & General Group Plc | 2024-06-30 | 432 K | |
| Ubs Asset Mgmt Americas Inc | 2024-09-30 | 408.7 K | |
| Hrt Financial Llc | 2024-06-30 | 383.8 K | |
| Berkshire Hathaway Inc | 2024-06-30 | 36.1 M | |
| Vanguard Group Inc | 2024-09-30 | 5.4 M |
DaVita HealthCare Historical Income Statement
DaVita Stock Against Markets
DaVita HealthCare Corporate Directors
| Paul Diaz | Independent Director | Profile | |
| John Nehra | Independent Director | Profile | |
| Phyllis Yale | Independent Director | Profile | |
| Pascal Desroches | Independent Director | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DaVita HealthCare. If investors know DaVita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DaVita HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Earnings Share 9.29 | Revenue Per Share 145.293 | Quarterly Revenue Growth 0.046 | Return On Assets 0.0694 |
The market value of DaVita HealthCare is measured differently than its book value, which is the value of DaVita that is recorded on the company's balance sheet. Investors also form their own opinion of DaVita HealthCare's value that differs from its market value or its book value, called intrinsic value, which is DaVita HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DaVita HealthCare's market value can be influenced by many factors that don't directly affect DaVita HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DaVita HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if DaVita HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DaVita HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.